Dementia Antipsychotics And Antidepressants Discontinuation Study

NCT00594269 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2011-02-23

No results posted yet for this study

Summary

The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).

Conditions

Interventions

DRUG

Risperidone

Discontinuation

DRUG

Escitalopram

Discontinuation

DRUG

Citalopram

Discontinuation

DRUG

Sertraline

Discontinuation

DRUG

Paroxetine

Discontinuation

Sponsors & Collaborators

  • Ullevaal University Hospital

    collaborator OTHER
  • Eikertun Nursing Home

    collaborator OTHER
  • University of Bergen

    collaborator OTHER
  • Innlandet Hospital Trust, Sanderud

    collaborator UNKNOWN
  • Innlandet Hospital Trust, Reinsvoll

    collaborator UNKNOWN
  • Diakonhjemmet Hospital

    collaborator OTHER
  • Sykehuset Telemark

    collaborator OTHER_GOV
  • The Nordmøre and Romsdal Hospital Trust

    collaborator UNKNOWN
  • Songdalstunet Nursing Home

    collaborator OTHER
  • Sykehuset Buskerud HF

    collaborator OTHER
  • Kroken Nursing Home, Tromsø

    collaborator OTHER
  • Kløveråsen, Bodø

    collaborator UNKNOWN
  • Bjørgene Omsorgssenter, Haugesund

    collaborator UNKNOWN
  • Alesund Hospital

    collaborator OTHER
  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Knut Engedal, Ph D · The Norwegian Centre for Dementia Research (NCDR), Norway

  • Sverre Bergh, MD · Innlandet Hospital Trust, Sanderud

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00594269 on ClinicalTrials.gov